Bioinformatic Description of Immunotherapy Targets for Pediatric T-Cell Leukemia and the Impact of Normal Gene Sets Used for Comparison
Pediatric lymphoid leukemia has the highest cure rate of all pediatric malignancies, yet due to its prevalence, still accounts for the majority of childhood cancer deaths and requires long-term highly toxic therapy. The ability to target B-cell ALL with immunoglobulin-like binders, whether anti-CD...
Main Authors: | Rimas J Orentas, Jessica eNordlund, Jianbin eHe, Sivasish eSindiri, Crystal eMackall, Terry J Fry, Javed eKhan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00134/full |
Similar Items
-
Paired Expression Analysis of Tumor Cell Surface Antigens
by: Rimas J. Orentas, et al.
Published: (2017-08-01) -
Beyond CD19: Opportunities for future development of targeted immunotherapy in pediatric relapsed-refractory acute leukemia
by: Haneen eShalabi, et al.
Published: (2015-10-01) -
Challenges in the Treatment of Glioblastoma by Chimeric Antigen Receptor T-Cell Immunotherapy and Possible Solutions
by: Peng Zhang, et al.
Published: (2022-07-01) -
CELLULAR IMMUNOTHERAPY: A MODERN APPROACH TO TREATMENT OF ONCOLOGICAL DISEASES
by: Yu. N. Lezhnin, et al.
Published: (2018-06-01) -
Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective
by: Chiara Donini, et al.
Published: (2021-03-01)